Risk Prediction Systems: One for all or all for Some

Paiter, Jorge; Oliveira, Gláucia Maria Moraes de

doi:10.36660/ijcs.20200372

Cited by 1 publication

(2 citation statements)

References 6 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Even though many medical instruments help to individually assess the CVR in a 10-year period, covering several clinical and laboratory data of the patient, they remain quite rough instruments [16][17][18]. However, CVR scales do not include other equally important RF that may directly affect the CVE prognosis over a 10-year period [19]. Treatment recommendations are based on data from the CVR, are group character that can reduce the effectiveness of individual therapy.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Assessment of Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Associated Obesity and Ways of Its Correction

et al. 2021

View full text Add to dashboard Cite

The aim: To analyze and calculate CVR in patients with T2DM and concomitant obesity. Materials and methods: The selection of patients was carried out based on the Uzhhorod District Clinical Hospital, in the period from November 2016 to January 2020. All patients were divided into 3 groups: 1 (n=93) with T2DM and concomitant obesity, 2 (n=87) with T2DM, 3 (n=39) with obesity. The treatment period lasted 1 year and included dosed exercise for at least 30 minutes per day and dietary recommendations. Patients in groups 1 and 2 received metformin 850 mg twice daily in combination with dapagliflozin 10 mg once daily. CVR was determined at the time of enrollment and after 1 year of treatment using: American College of Cardiology / American Heart Association Guideline on the Assessment of Cardiovascular Risk (2013) (ASCVD Risk) and Framingham Risk Score (FRS). Results: The data obtained as a result of the study revealed the highest CVR in patients of group 1, in contrast to group 2 and 3 (p<0.05). After 1 year of complex treatment, CVR indicators were statistically significantly reduced in all experimental groups (p<0.05). Conclusions: Determining CVR parameters and exposure to them within 10 years can remove unwanted cardiovascular complications.

show abstract

Section: Discussionmentioning

confidence: 99%

“…CVD is one of the leading causes of global mortality and one of the most common causes of disability. CVD prevalence increased from 271 million in 1990 to 523 million in 2019 and continues to rise, while the number of CVD deaths increased from 12.1 million in 1990 to 18.6 million in 2019 [19].…”

Section: Introductionmentioning

confidence: 99%